In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Aptevo Therapeutics Inc (NASDAQ: APVO) was $9.43 for the day, up 0.43% from the previous closing price of $9.39. In other words, the price has increased by $0.43 from its previous closing price. On the day, 0.19 million shares were traded. APVO stock price reached its highest trading level at $10.6569 during the session, while it also had its lowest trading level at $9.28.
Ratios:
Our analysis of APVO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.03. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.23.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 10 ’25 when Grant Grady III bought 13,513 shares for $1.49 per share. The transaction valued at 20,134 led to the insider holds 13,514 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 158900160 and an Enterprise Value of -7443209.
Stock Price History:
The Beta on a monthly basis for APVO is 1.45, which has changed by -0.9942925 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, APVO has reached a high of $1976.40, while it has fallen to a 52-week low of $9.07. The 50-Day Moving Average of the stock is -58.14%, while the 200-Day Moving Average is calculated to be -91.59%.
Shares Statistics:
APVO traded an average of 128.51K shares per day over the past three months and 131692 shares per day over the past ten days. A total of 0.94M shares are outstanding, with a floating share count of 0.94M. Insiders hold about 0.08% of the company’s shares, while institutions hold 129.51% stake in the company. Shares short for APVO as of 1765756800 were 57406 with a Short Ratio of 0.45, compared to 1763078400 on 43314. Therefore, it implies a Short% of Shares Outstanding of 57406 and a Short% of Float of 0.33999999999999997.
Earnings Estimates
The stock of Aptevo Therapeutics Inc (APVO) is currently in the spotlight, with 1.0 analysts actively rating and assessing its market standing. Analysts are recommending an EPS of between -$96.84 and -$96.84 for the fiscal current year, implying an average EPS of -$96.84. EPS for the following year is -$28.8, with 1.0 analysts recommending between -$28.8 and -$28.8.
